The dentist in the US state of California is prescribing a brand of dental hygiene product for people who have tooth decay and are sensitive to the ingredients.
The US Food and Drug Administration said it has approved an antibiotic called Ciprofloxacin for people with oral caries who may have had oral carious diseases before or during pregnancy, or have an underlying inflammatory condition.
Cipro was approved for oral carie patients in the UK for 10 years, the UK’s Medicines and Healthcare products Regulatory Agency said in a statement.
More: The product is approved for adults with oral cavity, pharyngeal and pharynx diseases, the FDA said.
Ciproc is a mixture of ciprolimus, a medication that reduces plaque and bacteria, and a synthetic antibiotic called ritonavir.
It is being sold under the brand name Gilead.CIPRO has been approved for treating the symptoms of oral carium in the United States, where it was used in the treatment of tooth decay in the 1980s, the CDC said.
The FDA said it was unaware of any deaths linked to the Ciproc products, but that people should not stop using it without first consulting their healthcare provider.
The agency said there was no evidence that the drug caused any health risks, although it noted that there was some risk of liver damage.
It also said that patients who were not taking their medications correctly should continue using Ciprog and Gileada products.
The US Centers for Disease Control and Prevention said the agency was aware of the case report and is working with the manufacturer to assess whether Ciprosporin is safe for use.
The Ciproxadine generic is currently available in the USA for $19.99 a tablet.